Finally, there is growing evidence that AIC may evolve to overt clonal diseases of myeloid or lymphoid lineages and no predictors are available (138C141). Genomic studies are limited in these forms, except for recurrent mutations of KMT2D and CARD11 in … Continue reading Finally, there is growing evidence that AIC may evolve to overt clonal diseases of myeloid or lymphoid lineages and no predictors are available (138C141)